| Autor: |
Jacques T. Weissman, Fabrice Piu, Mark R. Brann, Andria L. Del Tredici, Jian-Nong Ma, Norman Nash, Ethan S. Burstein, Tracy Spalding, Hans H. Schiffer, Erika A. Currier, David M. Weiner |
| Rok vydání: |
2006 |
| Předmět: |
|
| Zdroj: |
Current Pharmaceutical Design. 12:1717-1729 |
| ISSN: |
1381-6128 |
| DOI: |
10.2174/138161206776873662 |
| Popis: |
Chemical genomics is a drug discovery strategy that relies heavily on high-throughput screening (HTS) and therefore benefits from functional assay platforms that allow HTS against all relevant genomic targets. Receptor Selection and Amplification Technology (R-SAT™) is a cell-based, high-throughput functional assay where the receptor stimulus is translated into a measurable cellular response through an extensive signaling cascade occurring over several days. The large biological and chronological separation of stimulus from response provides numerous opportunities for enabling assays and increasing assay sensitivity. Here we review strategies for building homogeneous assay platforms across large gene families by redirecting and/or amplifying signal transduction pathways. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
